Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma

This study has been completed.
Information provided by (Responsible Party):
Chao Family Comprehensive Cancer Center, University of California, Irvine Identifier:
First received: November 17, 2005
Last updated: March 19, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)